Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 16, 2022
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
Justin Zelin Maintained (CASI) at Strong Buy with Decreased Target to $10 on, Nov 16th, 2022
Justin Zelin of BTIG, Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Decreased Target from $21 to $10 on, Nov 16th, 2022.
Justin has made no other calls on CASI in the last 4 months.
There are 2 other peers that have a rating on CASI. Out of the 2 peers that are also analyzing CASI, 0 agree with Justin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Justin
- Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, November 15th, 2022
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $12 on, Monday, August 15th, 2022
